Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

A novel immunosuppressive agent, sirolimus, in the treatment of Kaposi's sarcoma in a renal transplant recipient.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
  • معلومة اضافية
    • المصدر:
      Publisher: Informa Healthcare Country of Publication: England NLM ID: 8701128 Publication Model: Print Cited Medium: Internet ISSN: 1525-6049 (Electronic) Linking ISSN: 0886022X NLM ISO Abbreviation: Ren Fail Subsets: MEDLINE
    • بيانات النشر:
      Publication: London : Informa Healthcare
      Original Publication: New York, N.Y. : M. Dekker, c1987-
    • الموضوع:
      Immunosuppressive Agents/*therapeutic use ; Sarcoma, Kaposi/*drug therapy ; Sirolimus/*therapeutic use ; Skin Neoplasms/*drug therapy; Adult ; Female ; Humans ; Immunosuppression Therapy/adverse effects ; Kidney Transplantation ; Sarcoma, Kaposi/etiology ; Skin Neoplasms/etiology
    • نبذة مختصرة :
      Renal transplant recipients are susceptible to Kaposi's sarcoma (KS) because of treatment with immunosuppressive drugs. Sirolimus, a new immunosuppressive agent, has been successfully used for immune-suppression in kidney transplant recipients. Several studies have shown the potential role of sirolimus to inhibit progression of KS in kidney-transplant recipients. This report details a kidney-transplant recipient with cutaneous KS who had a complete remission in response to sirolimus therapy.
    • الرقم المعرف:
      0 (Immunosuppressive Agents)
      W36ZG6FT64 (Sirolimus)
    • الموضوع:
      Date Created: 20070317 Date Completed: 20080603 Latest Revision: 20211203
    • الموضوع:
      20250114
    • الرقم المعرف:
      10.1080/08860220601039528
    • الرقم المعرف:
      17365918